These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27428427)

  • 1. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.
    Friedrich T; Söhn M; Gutting T; Janssen KP; Behrens HM; Röcken C; Ebert MPA; Burgermeister E
    EBioMedicine; 2016 Jun; 8():159-172. PubMed ID: 27428427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.
    Niu Y; Roy F; Saltel F; Andrieu-Soler C; Dong W; Chantegrel AL; Accardi R; Thépot A; Foiselle N; Tommasino M; Jurdic P; Sylla BS
    Mol Cell Biol; 2006 Jun; 26(11):4288-301. PubMed ID: 16705178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOK1/PPARgamma pathway mediates anti-tumor ability of all-trans retinoic acid in breast cancer MCF-7 cells.
    Ding X; Wang W; Wang M; Wu J; Yao F
    Biochem Biophys Res Commun; 2017 May; 487(2):189-193. PubMed ID: 28396148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.
    Hosooka T; Noguchi T; Kotani K; Nakamura T; Sakaue H; Inoue H; Ogawa W; Tobimatsu K; Takazawa K; Sakai M; Matsuki Y; Hiramatsu R; Yasuda T; Lazar MA; Yamanashi Y; Kasuga M
    Nat Med; 2008 Feb; 14(2):188-93. PubMed ID: 18204460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
    Mercier PL; Bachvarova M; Plante M; Gregoire J; Renaud MC; Ghani K; Têtu B; Bairati I; Bachvarov D
    Mol Oncol; 2011 Oct; 5(5):438-53. PubMed ID: 21856257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain.
    Burgermeister E; Friedrich T; Hitkova I; Regel I; Einwächter H; Zimmermann W; Röcken C; Perren A; Wright MB; Schmid RM; Seger R; Ebert MP
    Mol Cell Biol; 2011 Aug; 31(16):3497-510. PubMed ID: 21690289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the DOK1 gene in breast cancer.
    Tuna E; Ersoy YE; Bulut P; Ozdemir F; Buyru N
    Mol Biol Rep; 2020 Mar; 47(3):1605-1612. PubMed ID: 31919752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68.
    Wang X; Yu H; Sun W; Kong J; Zhang L; Tang J; Wang J; Xu E; Lai M; Zhang H
    Mol Cancer; 2018 Jul; 17(1):110. PubMed ID: 30064438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain.
    Shi N; Ye S; Bartlam M; Yang M; Wu J; Liu Y; Sun F; Han X; Peng X; Qiang B; Yuan J; Rao Z
    J Biol Chem; 2004 Feb; 279(6):4962-9. PubMed ID: 14607833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
    Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1.
    Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE
    FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoactivation of Dok1/ERK/PPARγ signaling axis inhibits excessive lipolysis in insulin-resistant adipocytes.
    Jiang X; Huang L; Xing D
    Cell Signal; 2015 Jul; 27(7):1265-75. PubMed ID: 25813581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.
    Lamkin TJ; Chin V; Yen A
    Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Alternative Phosphorylation Switch in Integrin β2 (CD18) Tail for Dok1 Binding.
    Gupta S; Chit JC; Feng C; Bhunia A; Tan SM; Bhattacharjya S
    Sci Rep; 2015 Jun; 5():11630. PubMed ID: 26108885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.
    Lee S; Roy F; Galmarini CM; Accardi R; Michelon J; Viller A; Cros E; Dumontet C; Sylla BS
    Oncogene; 2004 Mar; 23(13):2287-97. PubMed ID: 14730347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of distinct interactions between Dok1 PTB domain and tyrosine-phosphorylated EGF receptor.
    Zhang Y; Yan Z; Farooq A; Liu X; Lu C; Zhou MM; He C
    J Mol Biol; 2004 Oct; 343(4):1147-55. PubMed ID: 15476828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction Analyses of 14-3-3ζ, Dok1, and Phosphorylated Integrin β Cytoplasmic Tails Reveal a Bi-molecular Switch in Integrin Regulation.
    Chatterjee D; D'Souza A; Zhang Y; Bin W; Tan SM; Bhattacharjya S
    J Mol Biol; 2018 Oct; 430(21):4419-4430. PubMed ID: 30243836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma Recurrence.
    Gutting T; Merkel A; Fink DJ; Hetjens S; Weidner P; Yu Y; Kähler G; Ebert MP; Gaiser T; Burgermeister E; Belle S
    J Gastrointestin Liver Dis; 2021 Dec; 30(4):446-455. PubMed ID: 34941983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ; Johnston DG; Lynch MA
    Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.